Tag Archives: ip

Centocor v. Abbott: Fed. Cir. Takes New Written Description Requirement Out For A Spin.

Posted on February 25, 2011 by Warren Woessner

In an important post-Ariad decision, the Federal Circuit reversed a district court decision that Abbott’s Humira infringed claims of a Centocor patent that could have cost Abbott $1.67 billion in damages. (A copy of the decision is at the end … Continue reading →

Posted in Written Description Requirements (WDR) | Tagged centocor v. abbott, Federal Circuit, humira, intellectual property, ip, Patent Law, patents, Warren Woessner, WDR | Leave a comment

Mumbo Jumbo: The Patentability of Biological Materials In Australia

Posted on February 25, 2011 by Warren Woessner

From Vaughn Barlow of Pizzeys Patent and Trade Mark Attorneys. 1. Introduction The Patent Amendment (Human Genes and Biological Materials) Bill (2010) is currently being debated before the Australian parliament. The Bill seeks to ban the patenting of all biological … Continue reading →

Posted in Non-U.S. Practice | Tagged Australia, biotechnology, biotechnology law, biotechnology news, intellectual property, ip, IP law tools, Patent Law, patents, Pizzeys, Vaughn Barlow, Warren Woessner | Leave a comment

European Union Patent Update

Posted on February 16, 2011 by Warren Woessner

Authored by Ms. Camilla Rendal Nielsen of Zacco Denmark A/S Latest news: Finally on the road towards an EU patent: Only Spain and Italy so far outside proposal to create a new EU-patent After failing to reach an agreement on … Continue reading →

Posted in Non-U.S. Practice | Tagged camilla rendal nielsen, denmark, EPO, european union, intellectual property, ip, IP law tools, Patent Law, patents, Warren Woessner, zacco | Leave a comment

Supplementary 112 Examination Guidelines – What’s In It For Me?

Posted on February 14, 2011 by Warren Woessner

This Post is from Mark Muller, Shareholder at Schwegman, Lundberg & Woessner, P.A. Supplementary examination guidelines for Section 112 were recently published in the Federal Register and sent out for public comment. While the details may not be too exciting, … Continue reading →